Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Lung cancer is the leading cause of death of all cancer. Metastatic lung cancer generally has a poor prognosis, with 0-1% 5 years survival. Systemic therapy is the mainstay of treatment. Brain metastases (BM) in patients with lung cancer are common. Approximately 30% to 55% of the patients will develop BM.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi